Home  |  About the Book  |  Table of Contents  |  Search  |  Archive  |  Order  |  Visit JCO  |  Visit ASCO.org
ASCO Educational Book; 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar content in this book
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Onciu, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Onciu, M.

The Pathologist's Perspective on Challenging Pediatric Lymphomas: Update on the Pathobiology of Uncommon Childhood Lymphomas

Mihaela Onciu, MD

From the Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN

Author's disclosure of potential conflicts of interest are found at the end of this article.

Address reprint requests to Mihaela Onciu, MD, Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105; e-mail: Mihaela.Onciu{at}StJude.org

Overview: Pediatric non-Hodgkin's lymphomas pose several types of challenges to the diagnosing pathologist and treating physician. Two rare types of low-grade B-cell lymphoma — follicular lymphoma and marginal zone lymphoma — show morphologic and immunophenotypic, as well as clinical, features unique to the pediatric age group. Additional difficulties relate to the occurrence of benign clonal B-cell proliferations, most commonly in children, that may mimic these two types of lymphoma at the morphologic and immunophenotypic levels. Other types of non-Hodgkin's lymphomas, most often peripheral T-cell lymphomas, have features common to those seen in adults. Their rarity in children represents mainly a therapeutic challenge. Lastly, diffuse large B-cell lymphomas occurring in children have distinct biologic features from those presenting in adults, raising the possibility of alternative therapeutic approaches.